BioXcel Archives -

BioXcel Therapeutics has claimed its first product approval, getting a green light from the FDA for Igalmi as

BioXcel gets first approval for agitation drug Igalmi

https://pharmaphorum.com/news/bioxcel-gets-first-approval-for-agitation-drug-igalmi/

A sublingual film for acute agitation in schizophrenia and bipolar disorder from BioXcel has blockbuster potential that could

BioXcel’s phase 3 schizophrenia film has blockbuster potential, say analysts

https://pharmaphorum.com/news/bioxcel/

US biotech BioXcel Therapeutics hopes to use wearable digital devices such as the Apple Watch to predict whether

BioXcel to trial Apple Watch-drug combination to prevent Alzheimer’s agitation episodes

https://pharmaphorum.com/news/bioxcel-to-trial-apple-watch-drug-combination-to-prevent-alzheimers-agitation-episodes/

The FDA has granted Fast Track Designation to BioXcel Therapeutics’ BXCL501 for the treatment of acute agitation resulting

BioXcel’s agitation drug gets FDA Fast Track

https://pharmaphorum.com/news/bioxcels-agitation-drug-gets-fda-fast-track/

BioXcel